Skip to main content
رجوع
PGEN logo

Precigen, Inc.

جودة البيانات: 100%
PGEN
NASDAQ Healthcare Biotechnology
KWD 3.24
▼ KWD 0.04 (-1.22%)
القيمة السوقية: 973.39M
نطاق اليوم
KWD 3.23 KWD 3.37
نطاق 52 أسبوعًا
KWD 1.11 KWD 5.47
حجم التداول
3,029,446
متوسط 50 يوم / 200 يوم
KWD 4.17 / KWD 3.40
الإغلاق السابق
KWD 3.28

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -7.7 0.4
P/B 25.3 2.9
ROE % -160.8 3.7
Net Margin % -3216.2 3.8
Rev Growth 5Y % -40.8 10.0
D/E 0.1 0.2

النقاط الرئيسية

Revenue declined -40.82% annually over 5 years
Debt/Equity of 0.14 — conservative balance sheet
Negative free cash flow of -76.76M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.87%
Capital intensive — 218.70% of revenue goes to capex

النمو

Revenue Growth (5Y)
-40.82%
Revenue (1Y)-36.95%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-160.80%
ROIC-230.08%
Net Margin-3216.18%
Op. Margin-3440.23%

الأمان

Debt / Equity
0.14
Current Ratio4.76
Interest Coverage-22504.83

التقييم

P/E Ratio
-7.71
P/B Ratio25.27
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -36.95% Revenue Growth (3Y) -61.81%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -40.82% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3.93M Net Income (TTM) -126.24M
ROE -160.80% ROA -86.90%
Gross Margin -8.71% Operating Margin -3440.23%
Net Margin -3216.18% Free Cash Flow (TTM) -76.76M
ROIC -230.08% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.14 Current Ratio 4.76
Interest Coverage -22504.83 Dividend Yield 0.00%
Valuation
P/E Ratio -7.71 P/B Ratio 25.27
P/S Ratio 248.00 PEG Ratio -0.12
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 973.39M Enterprise Value 949.37M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 3.93M 6.23M 26.91M 14.27M 31.99M
Net Income -126.24M -95.90M 28.32M -92.17M -170.52M
EPS (Diluted) -0.47 -0.39 -0.33 -0.47 -1.02
Gross Profit -342,000.0 106,000.0 20.57M -39.41M -12.81M
Operating Income -135.03M -99.76M -75.73M -91.95M -86.32M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 145.27M 151.04M 215.98M 359.86M 314.59M
Total Liabilities 106.75M 32.55M 89.72M 252.51M 247.41M
Shareholders' Equity 38.51M 118.50M 126.26M 107.35M 67.17M
Total Debt 5.50M 7.10M 51.42M 190.07M 182.28M
Cash & Equivalents 29.52M 7.58M 4.86M 36.42M 51.79M
Current Assets 102.41M 68.76M 118.16M 156.63M 148.95M
Current Liabilities 21.52M 22.99M 78.65M 34.65M 42.13M